EP-0042

DB18120InvestigationalSmall molecule

EP-0042: Overview.

Mechanism: Pharmacologically active on Receptor-type tyrosine-protein kinase FLT3, Aurora kinase A, and Aurora kinase B
Curator reviewed
Formula / weight: C₂₂H₂₃Cl₂N₇ · 456.38 g/mol (avg)
Also known as: 3H-IMIDAZO(4,5-B)PYRIDINE, 6-CHLORO-7-(4-((4-CHLOROPHENYL)METHYL)-1-PIPERAZINYL)-2-(1,3-DIMETHYL-1H-PYRAZOL-4-YL)-
Code names: CCT-241736 · EP-0042

Resolves to

Compound

Structure

InChIKeyAKJBLKUZXRMECW-UHFFFAOYSA-NSMILESCN1C=C(C(C)=N1)C1=NC2=C(N3CCN(CC4=CC=C(Cl)C=C4)CC3)C(Cl)=CN=C2N1

Targets

What you can answer from here — as of August 30, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with EP-0042, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.